- Home
- FULC vs NRC Comparison
FULC vs NRC Comparison
Compare FULC & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- NRC
- Stock Information
- Founded
- FULC 2015
- NRC 1981
- Country
- FULC United States
- NRC United States
- Employees
- FULC N/A
- NRC N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FULC Health Care
- NRC Health Care
- Exchange
- FULC Nasdaq
- NRC Nasdaq
- Market Cap
- FULC 372.2M
- NRC 354.5M
- IPO Year
- FULC 2019
- NRC N/A
- Fundamental
- Price
- FULC $6.40
- NRC $14.91
- Analyst Decision
- FULC Buy
- NRC
- Analyst Count
- FULC 8
- NRC 0
- Target Price
- FULC $7.13
- NRC N/A
- AVG Volume (30 Days)
- FULC 420.8K
- NRC 95.5K
- Earning Date
- FULC 07-29-2025
- NRC 10-24-2025
- Dividend Yield
- FULC N/A
- NRC 3.19%
- EPS Growth
- FULC N/A
- NRC N/A
- EPS
- FULC N/A
- NRC 0.77
- Revenue
- FULC N/A
- NRC $140,314,000.00
- Revenue This Year
- FULC N/A
- NRC N/A
- Revenue Next Year
- FULC N/A
- NRC N/A
- P/E Ratio
- FULC N/A
- NRC $19.57
- Revenue Growth
- FULC 2752.05
- NRC N/A
- 52 Week Low
- FULC $2.32
- NRC $9.76
- 52 Week High
- FULC $9.30
- NRC $22.99
- Technical
- Relative Strength Index (RSI)
- FULC 44.51
- NRC 48.76
- Support Level
- FULC $6.36
- NRC $14.51
- Resistance Level
- FULC $6.75
- NRC $15.25
- Average True Range (ATR)
- FULC 0.30
- NRC 0.60
- MACD
- FULC 0.01
- NRC -0.06
- Stochastic Oscillator
- FULC 19.59
- NRC 21.88
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.